Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Orca Biosystems, Inc.
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Milton S. Hershey Medical Center
Memorial Sloan Kettering Cancer Center
Syndax Pharmaceuticals
Memorial Sloan Kettering Cancer Center
Nantes University Hospital
Thomas Jefferson University
University of Nebraska
Boston Children's Hospital
Novartis
St. Petersburg State Pavlov Medical University
Medical College of Wisconsin
University of California, San Diego
St. Petersburg State Pavlov Medical University
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University
Seoul St. Mary's Hospital
St. Petersburg State Pavlov Medical University
University of Liege
Beijing 302 Hospital
City of Hope Medical Center
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
City of Hope Medical Center
Virginia Commonwealth University
University of Nebraska
Wake Forest University Health Sciences
National Institutes of Health Clinical Center (CC)
University of Nebraska
University Hospital, Clermont-Ferrand
First Affiliated Hospital of Zhejiang University
University of Liege
Memorial Sloan Kettering Cancer Center
IRCCS San Raffaele
Dana-Farber Cancer Institute
Mesoblast, Ltd.
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Shanghai Jiao Tong University School of Medicine
Kiadis Pharma
Kiadis Pharma
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Lund University Hospital
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Jonsson Comprehensive Cancer Center